More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura

被引：1

作者：

Picod, Adrien ^{[1
,2
]}

Benhamou, Ygal ^{[1
,3
,4
]}

Bouzid, Raida ^{[1
]}

Veyradier, Agnes ^{[1
,5
,6
]}

Coppo, Paul ^{[1
,7
,8
,9
]}

机构：

[1] Ctr Natl Reference MicroAngiopathies Thrombot, AP HP, Paris, France

[2] Hop Avicenne Assistance Publ, Hop Paris, AP HP, Serv reanimat Med chirurg, Bobigny, France

[3] CHU Charles Nicolle, Serv Med Interne, F-76031 Rouen, France

[4] UNIROUEN, Normandie Univ, F-76031 Rouen, France

[5] Univ Paris, Hop Lariboisiere, AP HP Nord, Lab ADAMTS13, Paris, France

[6] Univ Paris, Inst Rech St Louis, Paris, France

[7] Sorbonne Univ, Hop St Antoine, Assistance Publ Hop Paris, AP HP,AP HP 6,Serv Hematol, Paris, France

[8] Ctr Rech Cordeliers, Paris, France

[9] Hop St Antoine, AP HP, Ctr Natl Reference Microangiopathies thrombot, Serv hematol, 184 Rue Faubourg St Antoine, F-75012 Paris, France

来源：

BLOOD ADVANCES | 2023年 / 7卷 / 12期

关键词：

D O I：

10.1182/bloodadvances.2022009021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2678 / 2680

页数：3

共 14 条

[1] Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
Benhamou, Ygal
Assie, Cyrielle
Boelle, Pierre-Yves
Buffet, Marc
Grillberger, Rana
Malot, Sandrine
Wynckel, Alain
Presne, Claire
Choukroun, Gabriel
Poullin, Pascale
Provot, Francois
Gruson, Didier
Hamidou, Mohamed
Bordessoule, Dominique
Pourrat, Jacques
Mira, Jean-Paul
Le Guern, Veronique
Pouteil-Noble, Claire
Daubin, Cedric
Vanhille, Philippe
Rondeau, Eric
Palcoux, Jean-Bernard
Mousson, Christiane
Vigneau, Cecile
Bonmarchand, Guy
Guidet, Bertrand
Galicier, Lionel
Azoulay, Elie
Rottensteiner, Hanspeter
Veyradier, Agnes
Coppo, Paul
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1181 - 1186
[2] A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Coppo, Paul
Bubenheim, Michael
Azoulay, Elie
Galicier, Lionel
Malot, Sandrine
Bige, Naike
Poullin, Pascale
Provot, Francois
Martis, Nihal
Presne, Claire
Moranne, Olivier
Benainous, Ruben
Dossier, Antoine
Seguin, Amelie
Hie, Miguel
Wynckel, Alain
Delmas, Yahsou
Augusto, Jean-Francois
Perez, Pierre
Rieu, Virginie
Barbet, Christelle
Lhote, Francois
Ulrich, Marc
Rumpler, Anne Charvet
de Witte, Sten
Krummel, Thierry
Veyradier, Agnes
Benhamou, Ygal
[J]. BLOOD, 2021, 137 (06) : 733 - 742
[3] Redefining outcomes in immune TTP: an international working group consensus report
Cuker, Adam
Cataland, Spero R.
Coppo, Paul
de la Rubia, Javier
Friedman, Kenneth D.
George, James N.
Knoebl, Paul N.
Hovinga, Johanna A. Kremer
Laemmle, Bernhard
Matsumoto, Masanori
Pavenski, Katerina
Peyvandi, Flora
Sakai, Kazuya
Sarode, Ravi
Thomas, Mari R.
Tomiyama, Yoshiaki
Veyradier, Agnes
Westwood, John-Paul
Scully, Marie
[J]. BLOOD, 2021, 137 (14) : 1855 - 1861
[4] Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
del Rio-Garma, Julio
Bobillo, Sabela
de la Rubia, Javier
Pascual, Cristina
Garcia-Candel, Faustino
Garcia-Gala, Jose M.
Gonzalez, Reyes
Abril, Laura
Vidan, Julia
Gomez, Maria Jesus
Pena, Francisco
Arbona, Cristina
Martin-Sanchez, Jesus
Moreno, Gemma
Romon, Inigo
Viejo, Aurora
Oliva, Ana
Linares, Monica
Salinas, Ramon
Perez, Sonia
Garcia-Erce, Jose A.
Pereira, Arturo
[J]. ANNALS OF HEMATOLOGY, 2022, 101 (01) : 59 - 67
[5] Djulbegovic M, 2022, BLOOD ADV, Vbloodadvances
[6] Real-world experience with caplacizumab in the management of acute TTP
Dutt, Tina
Shaw, Rebecca J.
Stubbs, Matthew
Yong, Jun
Bailiff, Benjamin
Cranfield, Tanya
Crowley, Maeve P.
Desborough, Michael
Eyre, Toby A.
Gooding, Richard
Grainger, John
Hanley, John
Haughton, Joanna
Hermans, Joannes
Hill, Quentin
Humphrey, Louise
Lowe, Gillian
Lyall, Hamish
Mohsin, Muhammad
Nicolson, Phillip L. R.
Priddee, Nicole
Rampotas, Alexandros
Rayment, Rachel
Rhodes, Susan
Taylor, Alice
Thomas, William
Tomkins, Oliver
Van Veen, Joost J.
Lane, Steven
Toh, Cheng-Hock
Scully, Marie
[J]. BLOOD, 2021, 137 (13) : 1731 - 1740
[7] Pascual Izquierdo MC., 2022, BLOOD ADV, P2022008028, DOI [10.1182/bloodadvances.2022008028, DOI 10.1182/BLOODADVANCES.2022008028]
[8] Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis
Peyvandi, Flora
Cataland, Spero
Scully, Marie
Coppo, Paul
Knoebl, Paul
Hovinga, Johanna A. Kremer
Metjian, Ara
de la Rubia, Javier
Pavenski, Katerina
Edou, Jessica Minkue Mi
De Winter, Hilde
Callewaert, Filip
[J]. BLOOD ADVANCES, 2021, 5 (08) : 2137 - 2141
[9] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Peyvandi, Flora
Scully, Marie
Hovinga, Johanna A. Kremer
Cataland, Spero
Knoebl, Paul
Wu, Haifeng
Artoni, Andrea
Westwood, John-Paul
Taleghani, Magnus Mansouri
Jilma, Bernd
Callewaert, Filip
Ulrichts, Hans
Duby, Christian
Tersago, Dominique
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (06) : 511 - 522
[10] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Scully, M.
Cataland, S. R.
Peyvandi, F.
Coppo, P.
Knobl, P.
Hovinga, J. A. Kremer
Metjian, A.
de la Rubia, J.
Pavenski, K.
Callewaert, F.
Biswas, D.
De Winter, H.
Zeldin, R. K.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04) : 335 - 346

← 1 2 →